¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦17ȸ ¼­¿ï¾Æ»êº´¿ø ¿Ü°ú ¿¬¼ö°­Á : 2023-06-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦17ȸ ¼­¿ï¾Æ»êº´¿ø ¿Ü°ú ¿¬¼ö°­Á : 2023-06-17
±³À°ÀÏÀÚ : 2023-06-17
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦17ȸ ¼­¿ï¾Æ»êº´¿ø ¿Ü°ú ¿¬¼ö°­ÁÂ

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ±èÇüÀº
¿¬¶ôó : 02-3010-3480  

À̸ÞÀÏ : h0110@amc.seoul.kr

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:05~09:15 Clinicopathological Features and Long?Term Outcomes of Intraductal Papillary Neoplasms of the Bile Duct of the Liver: Single?Institution Experience with 146 Patients À±Á¤¹Î(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:15~09:25 Long-Term Exposure to Air Pollution and Incidence of Venous Thromboembolism in the General Population: A Population-Based Retrospective Cohort Study ÀÌ»ó¾Æ(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:25~09:35 A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology ÀÌÀμ·(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:35~09:45 Risk Factors for Cognitive Impairment in Critically Ill Surgical Patients Á¤±âÀç(¼­¿ï¾Æ»êº´¿ø ÁßȯÀÚ¿Ü»óÆÀ SICU1)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 09:45~10:05 Recent updates in liver transplantation À±¿µÀÎ(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:05~10:25 Recent update of thyroid stimulating hormone suppression in thyroid cancer ÀÌÀ¯¹Ì(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:25~10:45 Targeted Therapy for Vascular Malformations: A Promising Breakthrough in Treatment ±ÇÇöÈñ(¼­¿ï¾Æ»êº´¿ø)

ÈÞ½Ä 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 10:45~11:20 Coffee Break and Residents¡¯ Poster Presentation I ()

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 11:20~12:00 Surgery for carotid artery disease: AMC experience Á¶¿ëÇÊ(¼­¿ï¾Æ»êº´¿ø)

½Ä»ç 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 12:00~13:00 Lunch ()

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 13:00~14:00 ÇǺΠ¹Ì¿ë ½Ã¼úÀÇ ÃֽŠƮ·»µå¿Í ¿Ã¹Ù¸¥ ÇǺΠ³ëÈ­ ¿¹¹æ¹ý ¹®ÀÍÁØ(¼­¿ï¾Æ»êº´¿ø ÇǺΰú)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:00~14:15 Updates on Endoscopic Intervention in Gastric Neoplasm Á¤ÈÆ¿ë(¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â°ú)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:15~14:30 ÁßÀÔÀÚÄ¡·áÀÇ ÀÌÇØ¿Í ÀÓ»ó Àû¿ë ±è¿ë¹è(½ÅÃ̼¼ºê¶õ½ºº´¿ø ¹æ»ç¼±Á¾¾çÇаú)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:30~14:45 Chimeric antigen receptor T-cells (CAR-Ts): a versatile platform for engineered cell therapy of cancer À±´öÇö(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 14:45~15:00 Microbiome and Precision medicine ¹ÚÇѼö(GIST)

ÈÞ½Ä 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:00~15:30 Coffee Break and Residents¡¯ Poster Presentation II ()

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:30~15:45 Metabolic surgery for overweight patients(BMI >27.5 kg/m2); Expectation and Reality ±è¿ëÁø(H+¾çÁöº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 15:45~16:00 ÃéÀåÀ̽Ä, ±× µÎ¹ø° À̾߱â ÃÖº´Çö(¾ç»êºÎ»ê´ëº´¿ø )

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 16:00~16:15 Áö¿ª´ëÇк´¿ø¿¡¼­ÀÇ À¯¹æ¾Ï ȯÀÚÄ¡·á ¹ÚÀºÈ­(ºÎ»êµ¿¾Æ´ëº´¿ø)

±³À°½Ã°£ 06¿ù 17ÀÏ µ¿°ü 6Ãþ ´ë°­´ç 16:15~16:30 ³»°¡ ¾Æ»êº´¿ø¿¡¼­ ¹è¿î ¸ðµç °Íµé À¯À±½Ä(WÇ׿ܰú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦17ȸ ¼­¿ï¾Æ»êº´¿ø ¿Ü°ú ¿¬¼ö°­Á : 2023-06-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³âµµ Á¦ 17ȸ ´ëÇѳ»°úÇÐȸ ÃæºÏÁöȸ ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2023-06-17
´ÙÀ½±Û ÃæºÏ´ëÇб³º´¿ø Á¤Çü¿Ü°úÀDZ¹ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2023-06-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 3 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 107 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 9 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 24 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 10 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 5 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 4 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 6 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷